
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma
June 6, 2017 (HealthDay News) Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein A new type of immunotherapy appears to provide long-lasting protection against multiple …
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma Read More